Visit the Beamex web site
Click on the advert above to visit the company web site

Product category: Pharmaceutical Processing News
News Release from: MonoSol
Edited by the Processingtalk Editorial Team on 20 February 2004

New pharmaceutical development Vice
President

Request your FREE weekly copy of the Processingtalk email newsletter. News about Pharmaceutical Processing News and more every issue. Click here for details.

MonoSolRx LLC today announced that Dr Pradeep Sanghvi will join the Company as its Vice President of Pharmaceutical Development, from the oral drug development company, Penwest Pharmaceuticals

MonoSolRx LLC today announced that Dr Pradeep Sanghvi will join the Company as its Vice President of Pharmaceutical Development Dr Pradeep Sanghvi is joining MonoSolRx from the oral drug development company, Penwest Pharmaceuticals, where he served as Director of Pharmaceutical Development

Prior to Penwest, Dr Sanghvi was Director of Formulations and Process Development at the fast dissolve tablet company Fuisz Technologies, which was later acquired by Biovail.

MonoSolRx is a leading drug delivery company that uses film as a fast-dissolve oral drug delivery platform.

The MonoSolRx FDTAB film oral dosage form looks like a postage stamp and dissolves readily on the tongue to deliver drug to a patient, replacing the use of conventional tablets and capsules.

MonoSolRx also employs its proprietary film technology on a range of veterinary and nutraceutical products.

MonoSolRx was formed by MonoSol LLC, the leading producer of water soluble films.

MonoSolRx recently announced the acquisition of substantially all of the assets of the film drug delivery company, Kosmos Pharma.

MonoSolRx President and CEO P Scott Bening commented, "The selection of Dr Pradeep Sanghvi demonstrates the commitment of MonoSolRx to function as the leader, from day one, of film-based fast dissolve drug delivery.

Dr Sanghvi is an acknowledged leader in oral drug delivery and his joining MonoSolRx is excellent news for our pharmaceutical clients".

Dr Pradeep Sanghvi added, "I am thrilled to join MonoSolRx.

Their strong IP position and history of successful commercial manufacture offer a compelling value proposition to their pharmaceutical customers.

I look forward to working with the talented group at MonoSolRx combined with my oral drug delivery background to oversee the commercial launch of MonoSolRx products.

MonoSol: contact details and other news
Email this article to a colleague
Register for the free Processingtalk email newsletter
Processingtalk Home Page

Search the Pro-Talk network of sites

Visit the Beamex web site